Article Details

Survival Data for Palbociclib in ER+HER2– Advanced Breast Cancer Reported From ...

Retrieved on: 2022-06-05 18:03:57

Tags for this article:

Click the tags to see associated articles and topics

Survival Data for Palbociclib in ER+HER2– Advanced Breast Cancer Reported From .... View article details on HISWAI: https://www.cancernetwork.com/view/survival-benefit-of-palbociclib-for-er-her2-advanced-breast-cancer-confirmed-at-paloma-2-final-read-out

Excerpt

Final overall survival (OS) analysis of the phase 3 PALOMA-2 trial (NCT01740427) indicated that palbociclib (Ibrance) in combination with letrozole as ...

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up